WHO said over 118,000 new COVID-19 hospitalisations and over 1600...
Category:
Health
Latest
Ayushman Bharat Digital Mission ensures robust patient data security measures: NHA
Vikram Pagaria, joint director of the mission under the National...
New psychological intervention ‘EASE’ to help adolescents affected by distress
1 in 7 adolescents globally experience mental health conditions,...
PM Modi urges India to get COVID-19 shots amid Delta variant concerns
India must administer 10 million doses a day to achieve its aim of inoculating all adults by December, experts say. But the country has fully vaccinated fewer than 6% with two doses.
Availability of Covid vaccine for kids will pave way for school reopening: AIIMS chief
The government has recently cautioned that even though COVID-19 has not impacted children greatly till now, that can increase if there is a change in the behaviour of the virus or in epidemiology dynamics. It said that preparations are being made to deal with any such situation.
Study finds sleep apnea can worsen heart disease
According to the study, OSA occurs in 40 per cent to 80 per cent of people with cardiovascular disease, yet it is under-recognised and undertreated.Symptoms include snoring, lapses in breathing, fragmented sleep and daytime sleepiness. In general, about 34 per cent of middle-aged men and 17 per cent of middle-aged women meet the criteria for OSA.
Allow life insurers to play bigger role in healthcare ecosystem, Deepak Parekh urges Irdai
‘While we continue to invest to enhance our technological capabilities, I feel that the time is right for the regulator (Irdai) to allow life insurers in India to evolve further and be the disruptor rather than the disrupted,’ HDFC Life Chairman Deepak S Parekh said.
Antibodies triggered by Chinese COVID-19 shots less effective on Delta variant: researcher
Five out of the seven domestically developed vaccines in China’s mass inoculation scheme are inactivated vaccines. These include shots from Sinovac Biotech and Sinopharm used in countries such as Brazil, Bahrain and Chile.
Genetic study of liver cancer reveals new drug target
The conclusion of the new study analyzing the genetics of HCC tumours was published in the journal PLOS Genetics by Augusto Villanueva of the Icahn School of Medicine at Mount Sinai and colleagues.”The study uncovered the role of cancer-testis antigens, specifically MAGEA3, in liver cancer progression,” Villanueva adds.
Govt extends I-T compliance deadlines; exempts tax on COVID treatment cost, ex-gratia payments from employers
“In order to ensure that no income tax liability arises on this account, it has been decided to provide income-tax exemption to the amount received by a taxpayer for medical treatment from employer or from any person for treatment of Covid-19 during FY 2019-20 and subsequent years,” it added.
U.S. approves Roche drug for emergency use against severe COVID-19
The drug can be used to treat patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation, the FDA said, adding studies showed Actemra helped reduce the risk of death and speed recovery.
For months already, the medicine has been given to severely ill COVID-19 patients on a compassionate-use basis, generating hundreds of millions in sales for Roche.
Pfizer halts distribution of anti-smoking drug after finding carcinogen
The drugmaker is recalling a number of lots of anti-smoking drugs. The U.S. drug regulator has in the past reached out to companies whose drugs had N-nitrosodimethylamine (NDMA) over accepted levels.
The Food and Drug Administration (FDA) last year found high levels of NDMA in some versions of the popular diabetes drug metformin. NDMA contamination was responsible for the recall of the heartburn drug Zantac sold by Sanofi SA in 2019.
Third wave of coronavirus unlikely to be as severe as second wave: ICMR Study
Presenting a vaccine ramp-up scenario where 40 percent of the population has received two doses within three months of the second wave peak, and further that the effect of vaccination is (conservatively) to reduce severity of infection by 60 percent, the study said it illustrates how vaccination could substantially reduce the overall burden during the possible third wave.